-
Torcetrapib, a cholesteryl ester transfer protein (CETP) inhibitor, has been in development by Pfizer for nearly 15 years.
-
For women, up to 20% of all coronary events occur in the absence of traditional major risk factors, and many women with these risk factors do not develop coronary events.
-
Patients at high risk for VTE should be treated with three times daily UH, while patients at lower risk may be treated with twice daily therapy.
-
The ECG Figure in the article was obtained from an older woman who was seen in the Emergency Department with a chief complaint of weakness of several days duration.
-
Botulinum Toxin for Treatment of Hyperhidrosis; A Fish Story; Diabetes Control: It's More Than Just A1c Control; MI: Try to have it Monday Thru Friday; Can MRI Provide Better Clarity About Contralateral Breast Cancer?; Dapsone Gel 5% for Acne
-
The Annual Meeting of the Society of Gynecologic Oncologists (SGO) represents the one completely focused platform to exchange preclinical and clinical information in the subspeciality of gynecologic oncology. This year more that 1300 health care providers, researchers and industry representatives participated in a conference offering much more than distribution of the latest scientific and clinical advances.
-
Worldwide, coffee is a popular beverage used daily with increasing frequency. Caffeine, a dominant ingredient, has been implicated in many conditions including hormonally active cancer (due to its impact on sex hormone binding globulin [SHBG] homeostasis).
-
There is no doubt now that the cervical length (CL) measurement, obtained with transvaginal ultrasound between 20 and 24 weeks, can give the clinician a very reasonable idea about which patients have the greatest and smallest chances of delivering preterm.
-
-
Gonococcal Infections, CDC's Updated Treatment; Head Lice Malathion First-Line Treatment; Statins, May Cut the Risk of Cataracts; FDA Actions
